The utility of the 21-gene Oncotype DX Breast Recurrence Score^® assay in node-negative breast cancer patients - the final analysis of the Polish real-life survey PONDx.

In the overall population, oncologists changed their treatment decision from CT + ET to ET alone in 29.0% of post-menopausal patients and 27.1% of pre-menopausal patients, although these changes did not reach statistical significance.

also in 111,027 other papers